A carregar...

ALK Inhibitors in the Treatment of ALK Positive NSCLC

Background: ALK inhibitors have shown positive advance in the treatment of ALK+ NSCLC. They have achieved better results in prolonging the progression free survival and improving quality of life in comparison to chemotherapy. We have assembled the evidence related to the efficacy and safety of these...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Khan, Muhammad, Lin, Jie, Liao, Guixiang, Tian, Yunhong, Liang, Yingying, Li, Rong, Liu, Mengzhong, Yuan, Yawei
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6333640/
https://ncbi.nlm.nih.gov/pubmed/30687633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00557
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!